Features of structural and functional changes in the cardiovascular system and their correction in patients with chronic heart failure in combination with cardiopulmonary pathology

Features of structural and functional changes in the cardiovascular system and their correction in patients with chronic heart failure in combination with cardiopulmonary pathology

The article discusses the treatment for combined pathology of cardiovascular and respiratory systems, contains the results of authors own study on structural and functional changes in the myocardium of the left and right parts of the heartin patients with chronic heart failure and concomitant chroni...

Full description

Bibliographic Details
Main Authors:	V. V Evdokimov, E. V Kovalenko, A. G Evdokimova, T. A Komissarova, K. I Tebloev, G. V Voronina
Format:	Article
Language:	English
Published:	Concilium Medicum 2018-03-01
Series:	КардиоСоматика
Subjects:	cardiopulmonary disorders chronic heart failure chronic obstructive pulmonary disease nebivolol enalapril losartan
Online Access:	https://cardiosomatics.orscience.ru/2221-7185/article/viewFile/45945/pdf

Similar Items

Modern possibilities of correction of broncho-obstructive syndrome in chronic heart failure of ischemic origin in combination with chronic obstructive pulmonary disease: simple randomized parallel group study
by: Vladimir V. Evdokimov, et al.
Published: (2023-06-01)

The dynamics of 24-hour ambulatory blood pressure monitoring parameters, subclinical damage and endothelial function of vessels in patients with arterial hypertension and chronic obstructive pulmonary disease treated with S-amlodipine, Nebivolol and Enala
by: O. G. Ivanko, et al.
Published: (2017-02-01)

CHRONIC HEART FAILURE OF ISCHEMIC GENESIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POSSIBILITIES OF COMBINATION THERAPY INCLUDING NEBIVOLOL
by: P. A. Fedotov, et al.
Published: (2014-07-01)

CHRONIC HEART FAILURE OF ISCHEMIC GENESIS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: POSSIBILITIES OF COMBINATION THERAPY INCLUDING NEBIVOLOL
by: P. A. Fedotov, et al.
Published: (2014-07-01)

Cardiopulmonary rehabilitation in patiens with heart failure and chronic pulmonary disease
by: Pier Luigi Temporelli
Published: (2016-06-01)

Comparison of Anti Hypertensive Effect of Fixed Dose Enalapril and Losartan in Essential Hypertension
by: Khurram Mansoor
Published: (2009-06-01)

Losartan versus enalapril in dogs asymptomatic carriers of myxomatous degeneration of mitral valve
by: EDNA GOMEZ ORTIZ, et al.
Published: (2014-01-01)

COMPARATIVE ANALYSIS OF LOSATAN AND ENALAPRIL ANTIHYPERTENSIVE EFFICACY (ELLA TRIAL)
by: N. M. Chihladze, et al.
Published: (2016-01-01)

Antiproteinuric action of amiloride in paediatric patient with corticoresistant nephrotic syndrome
by: Miguel Liern, et al.
Published: (2021-05-01)

Acción antiproteinúrica del amiloride en el paciente pediátrico con síndrome nefrótico corticorresistente
by: Miguel Liern, et al.
Published: (2021-05-01)

RENIN-ANGIOTENSIN PROFILE AND COMPARATIVE EFFECTIVENESS OF FIRST-LINE MEDICATIONS IN MONOTHERAPY OF ESSENTIAL ARTERIAL HYPERTENSION
by: Sh. V. Akhadov, et al.
Published: (2010-06-01)

ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 2-3 DEGREE WITH FIXED COMBINATION OF ENALAPRIL OR LOSARTAN WITH HYDROCHLOROTHIAZIDE
by: A. A. Kudryavtsev, et al.
Published: (2016-01-01)

RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
by: M. L. Maximov
Published: (2015-12-01)

Age, sex, antihypertensive drugs and the Mediterranean diet on hypertension-related biomarkers: Impact on carotid structure and blood lipids in an Argentinian cross-sectional study
by: Georgina Noel Marchiori, et al.
Published: (2024-03-01)

Features of zofenopril and enalapril in patients with stable ischemic heart disease in combination with arterial hypertension
by: A. G Evdokimova, et al.
Published: (2016-06-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE
by: S. N. Tereshchenko, et al.
Published: (2016-01-01)

NEBIVOLOL ROLE IN THE CORRECTION OF INTRACARDIAC HEMODYNAMICS IN PATIENTS WITH CHRONIC HEART FAILURE
by: R. L. Dzhanaeva, et al.
Published: (2012-02-01)

NEBIVOLOL SAFETY AS CARDIOSELECTIVE Β-BLOCKER IN COMPLEX THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE ACCOMPANIED BY CHRONIC OBSTRUCTIVE BRONCHITIS
by: Zh. G. Simonova, et al.
Published: (2003-10-01)

THE RELATIVE INFLUENCE OF ENALAPRIL AND LOSARTAN ON THE DIURNAL PROFILE OF ARTERIAL PRESSURE IN HYPERTENSIVE PATIENTS
by: V. A. Azizov, et al.
Published: (2012-03-01)

Assessment of the effect of nebivolol and сarvedilol on the functional state of patients with diastolic chronic heart failure
by: Vitalii G. Tregubov, et al.
Published: (2021-02-01)

Impact Of Peak Oxygen Pulse On Patients With Chronic Obstructive Pulmonary Disease
by: Wu CW, et al.
Published: (2019-11-01)

Comparative clinical evaluation of Boerhavia diffusa root extract with standard Enalapril treatment in Canine chronic renal failure
by: Nethaji Lokeswar Oburai, et al.
Published: (2015-01-01)

Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease
by: E. I. Leonova, et al.
Published: (2016-03-01)

Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease
by: E. I. Leonova, et al.
Published: (2017-01-01)

Cardiopulmonary factors associated with atrial fibrillation in patients with chronic obstructive pulmonary disease
by: E. I. Leonova, et al.
Published: (2017-01-01)

Editorial: CardioPulmonary Physiology: Novel Approaches to Pulmonary Function and Critical Care
by: Zhanqi Zhao, et al.
Published: (2022-01-01)

Editorial: Progresses in the Drug Treatment of Chronic Cardiopulmonary Diseases
by: Xiaohui Li, et al.
Published: (2022-05-01)

DIFFERENCES IN EFFECTIVENESS OF ANTIHYPERTENSIVE THERAPY IN MEN AND WOMEN: LOSARTAN VERSUS ENALAPRIL
by: E. I. Tarlovskaya, et al.
Published: (2016-01-01)

Cardiovascular pathology in patients with newly diagnosed tuberculosis and chronic obstructive pulmonary disease
by: N. V. Bagisheva, et al.
Published: (2021-10-01)

Improved hemodynamics and cardiopulmonary function in patients with inoperable chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty
by: Qi Jin, et al.
Published: (2019-11-01)

Clinical characteristics of the respiratory and cardiovascular systems in patients with combination of chronic obstructive pulmonary disease and heart failure
by: I. I. Vyshnyvetskyy, et al.
Published: (2017-06-01)

Evaluation of exercise capacity in chronic obstructive pulmonary disease patients with pulmonary hypertension
by: Ashraf Z E-A Mohamed, et al.
Published: (2024-01-01)

Risk for Cardiovascular Disease and One-Year Mortality in Patients With Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Syndrome Overlap Syndrome
by: Manyun Tang, et al.
Published: (2021-10-01)

Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands
by: Karin M. A. Swart, et al.
Published: (2023-11-01)

Therapy correction of concerned chronic heart failure and chronic obstructive pulmonary disease in a patient with first identified pulmonary tuberculosis. Case report
by: Natalia V. Bagisheva, et al.
Published: (2022-05-01)

COMBINED AND ORGAN-PROTECTIVE ANTI-HYPERTENSION THERAPY: POSSIBILITIES OF FIXED COMBINATION OF NITRENDIPINE AND ENALAPRIL
by: A. G. EVDOKIMOVA, et al.
Published: (2016-12-01)

Prognostic Relevance of Cardiopulmonary Exercise Testing for Patients with Chronic Thromboembolic Pulmonary Hypertension
by: Ralf Ewert, et al.
Published: (2022-10-01)

Cardiovascular risk in patients with chronic obstructive pulmonary disease and metabolic syndrome
by: S. Nikolaeva, et al.
Published: (2023-07-01)

SECONDARY PULMONARY HYPERTENSION: SOME ASPECTS OF PATHOGENESIS
by: G V Neklyudova, et al.
Published: (2012-03-01)

Assessment of fitness and exercise tolerance of chronic obstructive pulmonary disease patients in correlation with their lifestyle
by: Mohammad A. E. Faramawy, et al.
Published: (2016-02-01)